121
Views
0
CrossRef citations to date
0
Altmetric
Original Research

Epidemiology and Drug Resistance of Pathogens Isolated from Cerebrospinal Fluids at a Children’s Medical Center in Eastern China During 2006–2020

, , , , , & show all
Pages 5417-5428 | Published online: 16 Dec 2021

References

  • Gonzalez-Granado LI. Acute bacterial meningitis. Lancet Infect Dis. 2010;10(9):596. doi:10.1016/S1473-3099(10)70184-5
  • Brouwer MC, Tunkel AR, van de Beek D. Epidemiology, diagnosis, and antimicrobial treatment of acute bacterial meningitis. Clin Microbiol Rev. 2010;23(3):467–492. doi:10.1128/CMR.00070-0920610819
  • WHO and partners call for urgent action on meningitis; 2021. Available from: https://www.who.int/news/item/28-09-2021-who-and-partners-call-for-urgent-action-on-meningitis. Accessed September 28, 2021.
  • Li Y, Yin Z, Shao Z, et al. Population-based surveillance for bacterial meningitis in China, September 2006-December 2009. Emerg Infect Dis. 2014;20(1):61–69. doi:10.3201/eid2001.12037524377388
  • Zhou T, Kuang M, Huang S, et al. Epidemiological characteristics and drug resistance analysis of cerebrospinal fluid microbial infections in Wenzhou Area. Infect Drug Resist. 2021;14:2091–2103. doi:10.2147/IDR.S31217534113136
  • Chang JB, Wu H, Wang H, et al. Prevalence and antibiotic resistance of bacteria isolated from the cerebrospinal fluid of neurosurgical patients at Peking Union Medical College Hospital. Antimicrob Resist Infect Control. 2018;7:41. doi:10.1186/s13756-018-0323-329568514
  • Jiang H, Su M, Kui L, et al. Prevalence and antibiotic resistance profiles of cerebrospinal fluid pathogens in children with acute bacterial meningitis in Yunnan province, China, 2012–2015. PLoS One. 2017;12(6):e0180161. doi:10.1371/journal.pone.018016128662145
  • Sanguinetti M, Posteraro B, Beigelman-Aubry C, et al. Diagnosis and treatment of invasive fungal infections: looking ahead. J Antimicrob Chemother. 2019;74(Suppl2):ii27–ii37. doi:10.1093/jac/dkz04131222314
  • Christaki E, Marcou M, Tofarides A. Antimicrobial resistance in bacteria: mechanisms, evolution, and persistence. J Mol Evol. 2020;88(1):26–40. doi:10.1007/s00239-019-09914-331659373
  • Hu F, Zhu D, Wang F, et al. Current status and trends of antibacterial resistance in China. Clin Infect Dis. 2018;67(suppl2):S128–S134. doi:10.1093/cid/ciy65730423045
  • Algammal AM, Hetta HF, Elkelish A, et al. Methicillin-resistant Staphylococcus aureus (MRSA): one health perspective approach to the bacterium epidemiology, virulence factors, antibiotic-resistance, and zoonotic impact. Infect Drug Resist. 2020;13:3255–3265. doi:10.2147/IDR.S27273333061472
  • Miao M, Wen H, Xu P, et al. Genetic diversity of carbapenem-resistant Enterobacteriaceae (CRE) clinical isolates from a tertiary hospital in eastern China. Front Microbiol. 2019;9:3341. doi:10.3389/fmicb.2018.0334130697205
  • Makharita RR, El-Kholy I, Hetta HF, et al. Antibiogram and genetic characterization of carbapenem-resistant gram-negative pathogens incriminated in healthcare-associated infections. Infect Drug Resist. 2020;13:3991–4002. doi:10.2147/IDR.S27697533177849
  • Houri H, Tabatabaei SR, Saee Y, et al. Distribution of capsular types and drug resistance patterns of invasive pediatric Streptococcus pneumoniae isolates in Teheran, Iran. Int J Infect Dis. 2017;57:21–26. doi:10.1016/j.ijid.2017.01.02028131730
  • Yi M, Wang L, Xu W, et al. Species distribution and antibiotic susceptibility of Nocardia isolates from Yantai, China. Infect Drug Resist. 2019;12:3653–3661. doi:10.2147/IDR.S23209831819548
  • AbdulWahab A, Taj-Aldeen SJ, Ibrahim EB, et al. Discrepancy in MALDI-TOF MS identification of uncommon Gram-negative bacteria from lower respiratory secretions in patients with cystic fibrosis. Infect Drug Resist. 2015;8:83–88. doi:10.2147/IDR.S8034125995646
  • Houri H, Pormohammad A, Riahi SM, et al. Acute bacterial meningitis in Iran: systematic review and meta-analysis. PLoS One. 2017;12(2):e0169617. doi:10.1371/journal.pone.016961728170400
  • Kang H, Zheng W, Kong Z, et al. Disease burden and molecular epidemiology of carbapenem-resistant Klebsiella pneumonia infection in a tertiary hospital in China. Ann Transl Med. 2020;8(9):605. doi:10.21037/atm.2020.03.12232566631
  • Gu B, Bi R, Cao X, et al. Clonal dissemination of KPC-2-producing Klebsiella pneumoniae ST11 and ST48 clone among multiple departments in a tertiary teaching hospital in Jiangsu Province, China. Ann Transl Med. 2019;7(23):716. doi:10.21037/atm.2019.12.0132042732
  • Magiorakos AP, Srinivasan A, Carey RB, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012;18(3):268–281. doi:10.1111/j.1469-0691.2011.03570.x21793988
  • Li Y, Li D, Xue J, et al. The epidemiology, virulence and antimicrobial resistance of invasive Klebsiella pneumoniae at a children’s medical center in eastern China. Infect Drug Resist. 2021;14:3737–3752. doi:10.2147/IDR.S32335334548798
  • Algammal AM, Hashem HR, Alfifi KJ, et al. atpD gene sequencing, multidrug resistance traits, virulence-determinants, and antimicrobial resistance genes of emerging XDR and MDR-Proteus mirabilis. Sci Rep. 2021;11(1):9476. doi:10.1038/s41598-021-88861-w33947875
  • Shen H, Zhu C, Liu X, et al. The etiology of acute meningitis and encephalitis syndromes in a sentinel pediatric hospital, Shenzhen, China. BMC Infect Dis. 2019;19(1):560. doi:10.1186/s12879-019-4162-531242869
  • Gaschignard J, Levy C, Romain O, et al. Neonatal bacterial meningitis: 444 Cases in 7 years. Pediatr Infect Dis J. 2011;30(3):212–217. doi:10.1097/inf.0b013e3181fab1e721416693
  • Sadarangani M, Pollard AJ. Bacterial meningitis in childhood. Adv Exp Med Biol. 2011;719:185–199. doi:10.1007/978-1-4614-0204-6_1622125045
  • Madhi SA. Pneumococcal conjugate vaccine and changing epidemiology of childhood bacterial meningitis. J Pediatr. 2015;91(2):108–110. doi:10.1016/j.jped.2014.11.001
  • Chen K, Zhang X, Tao Y, et al. Hospitalization for invasive pneumococcal diseases in young children before use of 13-valent pneumococcal conjugate vaccine, Suzhou, China. Emerg Infect Dis. 2021;27(1):69–75. doi:10.3201/eid2701.18141533350921
  • McCormick DW, Wilson ML, Mankhambo L, et al. Risk factors for death and severe sequelae in Malawian children with bacterial meningitis, 1997–2010. Pediatr Infect Dis J. 2013;32(2):e54–61. doi:10.1097/INF.0b013e31826faf5a22914560
  • Namani S, Milenkovic Z, Kuchar E, et al. Mortality from bacterial meningitis in children in Kosovo. J Child Neurol. 2012;27(1):46–50. doi:10.1177/088307381141328021765151
  • Edmond K, Clark A, Korczak VS, et al. Global and regional risk of disabling sequelae from bacterial meningitis: a systematic review and meta-analysis. Lancet Infect Dis. 2010;10(5):317–328. doi:10.1016/S1473-3099(10)70048-720417414
  • Okike IO, Johnson AP, Henderson KL, et al. Incidence, etiology, and outcome of bacterial meningitis in infants aged <90 days in the United Kingdom and Republic of Ireland: prospective, enhanced, national population-based surveillance. Clin Infect Dis. 2014;59(10):e150–e157. doi:10.1093/cid/ciu51424997051